Skip to main content

Platelet Endothelial Aggregation Receptor 1

Project description

New insight into blood clotting: implications for thrombosis treatment?

Cardiovascular disease, the leading cause of death worldwide, often leads to myocardial infarction and ischemic stroke due to occlusive thrombus formation. Blood clotting is a complex process that involves many different cell types and factors. Scientists of the EU-funded PAELLA project propose to study the role of the newly identified platelet receptor PEAR1 on haemostasis, inflammation and thrombosis. Through state-of-the-art methodologies, they will activate the receptor and study its impact on platelets, testing the hypothesis that PEAR1 drives thrombo-inflammatory disease in the vasculature. The work will unveil novel aspects in the blood clotting process and may lead to new treatment strategies to combat thrombosis.

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

THE UNIVERSITY OF BIRMINGHAM
Address
Edgbaston
B15 2TT Birmingham
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 212 933,76